Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Axonics Modulation Technologies, Inc. (AXNX)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Axonics Modulation Technologies, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Axonics Modulation Technologies, Inc. since 2005.
The reporting company's ticker symbol is AXNX. The reporting company's CIK number is 1603756.
The total value of stock buying since 2005 is $70,180,623.
The total value of stock sales since 2005 is $18,063,057.
The total value of stock option exercises since 2005 is $113,181.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2020-01-13||Cohen Raymond W (Chief Executive Officer)||Sale||10,000||31.98||319,800|
|2020-01-13||Cohen Raymond W (Chief Executive Officer)||Option Ex||10,000||1.63||16,299|
|2020-01-02||Sama Rinda (Chief Operating Officer)||Sale||5,000||27.42||137,105|
|2019-12-19||Dearen Danny L. (See Remarks)||Sale||30,000||26.07||782,100|
|2019-12-05||Sama Rinda (Chief Operating Officer)||Sale||5,000||23.92||119,620|
|2019-12-02||Woock John (Chief Marketing Officer)||Sale||15,000||23.82||357,285|
|2019-11-22||Biodiscovery 4 Fcpr||Sale||300,000||20.73||6,220,500|
|2019-11-21||Dearen Danny L. (See Remarks)||Sale||30,000||21.61||648,240|
|2019-11-19||Dearen Danny L. (See Remarks)||Sale||30,000||20.73||622,050|
|2019-11-19||Cohen Raymond W (Chief Executive Officer)||Sale||75,000||20.73||1,555,125|
|2019-10-30||Sama Rinda (Chief Operating Officer)||Sale||5,000||23.00||115,010|
|2019-10-01||Sama Rinda (Chief Operating Officer)||Sale||5,000||26.61||133,075|
|2019-08-06||Cohen Raymond W (Chief Executive Officer)||Buy||3,500||30.41||106,438|
|2019-07-23||Noblett Karen (Chief Medical Officer)||Option Ex||14,404||1.30||18,797|
|2019-07-02||Williamson Michael V. (SVP, General Counsel)||Sale||2,944||43.00||126,592|
|2019-07-01||Williamson Michael V. (SVP, General Counsel)||Sale||2,056||42.51||87,396|
|2019-06-28||Pardo Geoff||Option Ex||4,167||14.80||61,671|
|2019-06-27||Snyderman Nancy Lynn Md||Buy||2,000||37.12||74,240|
|2019-06-17||Williamson Michael V. (SVP, General Counsel)||Sale||5,000||36.01||180,060|
|2019-05-09||Sama Rinda (Chief Operating Officer)||Sale||13,345||28.02||373,993|
|2019-05-09||Sama Rinda (Chief Operating Officer)||Option Ex||13,345||1.23||16,414|
|2018-11-02||Pardo Geoff (Director)||Buy||866,666||15.00||12,999,990|
|2018-11-02||Cooperatieve Gilde Healthcare Iv U.a. (10% Owner)||Buy||866,666||15.00||12,999,990|
|2018-11-02||Biodiscovery 4 Fcpr (10% Owner)||Buy||866,666||15.00||12,999,990|
|2018-11-02||Longitude Venture Partners Iii, L.p. (10% Owner)||Buy||533,333||15.00||7,999,995|
|2018-11-02||Wisniewski Raphael (Director)||Buy||866,666||15.00||12,999,990|
|2018-11-02||Tammenoms Bakker Juliet (Director)||Buy||533,333||15.00||7,999,995|
|2018-10-31||Cormorant Global Healthcare Master Fund, Lp||Buy||133,333||15.00||1,999,995|
Insider trading activities including stock purchases, stock sales, and option exercises of AXNX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Axonics Modulation Technologies, Inc. (symbol AXNX, CIK number 1603756) see the Securities and Exchange Commission (SEC) website.